As is known, TDP-43 aggregation in AD brains occurs after Tau aggregation [293], but TDP-43 can synergize with Tau, enhance Tau aggregation and neurotoxicity and, finally, accelerate progressive neurodegeneration [273,298,307]. Here, MAPT is linked to Alzheimer disease.